Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Artificial Intelligence: The Latest Advances in the Diagnosis of Bladder Cancer
3
Zitationen
2
Autoren
2024
Jahr
Abstract
Bladder cancer remains a significant health challenge. Early and accurate diagnoses are crucial for effective treatment and improved patient outcomes. In recent years, artificial intelligence (AI) has emerged as a powerful tool in the medical field, showing great promise in advancing the bladder cancer diagnosis. This review explores the current state and potential of AI technologies, including machine learning algorithms, deep learning networks, and computer vision, in enhancing the diagnostic process for bladder cancer. AI systems can analyze vast amounts of data from various sources, such as medical imaging, genomic data, and electronic health records, enabling the identification of subtle patterns and biomarkers that may indicate the presence of bladder cancer. These systems have demonstrated high accuracy in detecting cancerous lesions in imaging modalities such as cystoscopy, ultrasonography, and computed tomography scans, often surpassing human performance. Moreover, AI-driven diagnostic tools can assist in risk stratification, predicting disease progression, and personalizing treatment plans, thereby contributing to more targeted and effective therapies.
Ähnliche Arbeiten
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
2008 · 28.817 Zit.
TNM Classification of Malignant Tumours
1987 · 16.123 Zit.
A survey on deep learning in medical image analysis
2017 · 13.514 Zit.
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
2011 · 10.745 Zit.
The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
2010 · 9.103 Zit.